arrow
H

Hritvik Jain

Allegheny General Hospital
H指数:12
被引数:602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment

卡格里斯玛与司美格鲁肽单药治疗或安慰剂治疗肥胖的疗效比较:一项基于GRADE评估的随机对照试验系统评价和荟萃分析

2026-05-150
PRE
Cyclooxygenase-2 (COX-2) as a Potential Prognostic Marker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

环氧化酶-2 (COX-2) 作为口腔鳞状细胞癌潜在预后标志物:一项系统评价和荟萃分析

2026-04-190
OAAI
Alveolar Soft Part Sarcoma Clinicopathologic Analysis, Predictive Nomogram, and the Role of Adjuvant Radiation for Survival in a Retrospective Population-based Study

肺泡软部分肉瘤的临床病理分析、预测诺模图及辅助放疗在生存中的作用:一项基于人群的回顾性研究

2026-02-010
PRE
Oral anticoagulation with versus without antiplatelet therapy in patients with stable coronary artery disease and an indication for anticoagulation: a meta-analysis with trial sequential analysis

稳定型冠状动脉疾病且具有抗凝指征的患者中,单用抗凝剂与联用抗血小板疗法的效果比较:一项含试验序贯分析的荟萃分析

2026-01-012
PRE
Trends and disparities in ischemic heart disease mortality in the United States: an analysis of CDC WONDER database, 1999-2020

美国缺血性心脏病死亡率的变化趋势与差异:一项基于CDC WONDER数据库(1999-2020年)的分析

2025-12-010
PRE
Nationwide trends and disparities in deaths from second- or third-degree atrioventricular block (1999-2022): A 24-year retrospective analysis of CDC WONDER data

全国范围内二度或三度房室传导阻滞死亡的趋势和差异(1999-2022年):一项基于CDC WONDER数据的24年回顾性分析

2025-11-010
OAAI
Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials

秋水仙碱在冠状动脉疾病患者中的疗效与安全性:一项随机对照试验的更新meta分析

2025-09-010
OAAI